Although PPAR-γ synthetic ligands such as TZDs and NSAIDs appear to be very promising drugs totreat severe human diseases, from cancer to metabolic diseases to braindiseases, several open issues still need to be examined. This evidence concerns the gene PPARG and metabolic disease.